Propellon Therapeutics Inc. (Triphase Accelerator)
oicr.on.ca
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Exit
Fund:
Development of WDR5 Inhibitors for Leukemia and Solid Tumours